TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
GSK

GlaxoSmithKline PLC

Healthcare · Drug Manufacturers - General

50.50$ +0.3% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios GSK
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
17.5 19.3 22.1
3.1 3.4 3.2
6.1 4.8 6.1
3.5 3.5 3.2
9.9 10.2 9.9
16.1 18.0 15.2
6.2% 5.5% 6.6%
Margins
64.9% 66.7% 66.7% 65.9% 65.8% 65.7% 66.0% 67.0% 67.3% 66.8% 66.1% 65.6% 65.1% 64.9% 65.0% 65.3% 65.6% 65.7% 66.1% 66.6% 67.2% 66.4% 65.3% 65.0% 65.1% 67.4% 69.8% 70.9% 71.7% 71.8% 72.0% 72.1% 71.6% 71.2% 71.4% 71.4% 72.3% 72.4% 72.7% 72.7%
6.6% 9.3% 12.4% 12.5% 13.8% 13.5% 12.0% 14.7% 14.7% 17.8% 18.1% 20.1% 20.0% 20.6% 21.5% 25.5% 25.2% 22.8% 23.0% 19.2% 18.9% 17.8% 20.0% 18.7% 17.3% 21.9% 21.4% 24.8% 27.1% 22.2% 20.0% 18.0% 12.4% 12.8% 15.1% 16.2% 23.4% 25.5% 25.7% 20.7%
1.1% 3.3% 5.8% 6.5% 7.7% 5.1% 3.4% 5.5% 6.2% 11.8% 12.5% 13.9% 13.8% 13.8% 15.3% 19.1% 18.6% 16.9% 16.2% 14.3% 15.8% 15.6% 18.2% 15.7% 45.1% 50.9% 50.2% 52.5% 20.4% 16.2% 14.6% 12.8% 8.0% 8.2% 10.0% 10.8% 17.1% 17.5% 17.8% 14.5%
10.3% 14.9% 17.2% 15.5% 15.8% 15.6% 15.0% 16.9% 17.6% 21.5% 20.7% 19.7% 20.1% 17.4% 17.4% 22.1% 17.2% 20.9% 20.0% 17.2% 28.9% 28.9% 36.0% 34.9% 27.0% 18.6% 10.3% 8.8% 10.7% 16.6% 20.8% 20.0% 18.8% 12.9% 12.3% 14.8% 18.5% 19.1% 19.0% 21.0%
Returns
218.1% 81.1% 97.8% 238.1% 180.4% 45.0% 41.6% 83.1% 97.3% 122.5% 38.7% 30.7% 33.1% 39.8% 34.5% 28.8% 25.6% 20.7% 21.7% 22.5% 38.1% 23.9% 139.1% 140.8% 100.0% 95.4% 37.7% 29.0% 25.6% 22.2% 17.9% 18.8% 17.3% 16.9% 25.3% 35.0% 24.8% 27.5%
0.5% 1.5% 2.8% 3.3% 4.0% 2.7% 1.8% 2.9% 3.2% 6.2% 6.3% 7.0% 5.5% 4.4% 5.1% 6.4% 6.1% 5.2% 4.9% 4.1% 4.3% 4.3% 6.7% 4.4% 21.1% 24.8% 20.2% 20.4% 8.1% 6.6% 6.1% 5.5% 4.3% 4.3% 4.0% 4.2% 6.7% 9.4% 7.0% 7.9%
Balance Sheet & Debt
19,391 17,319 17,535 18,557 19,154 18,290 19,122 31,744 31,466 89,156 27,625 29,337 28,744 26,519 27,836 23,005 24,150 19,916 20,860 22,567 22,645 19,660 29,528 14,973 18,414 17,264 18,339 19,089 18,026 13,997 -220 511 12,867 12,359 13,239 13,181 14,302 14,324 2,113 1,179
6.0 3.9 3.4 3.1 2.7 3.0 3.3 5.5 5.6 12.0 3.3 3.0 2.9 2.6 2.9 2.2 2.4 1.8 1.9 2.3 2.4 2.6 3.7 1.8 2.3 1.9 2.0 1.9 1.8 1.5 0.0 0.1 1.9 1.9 1.7 1.5 1.3 1.2 0.2 0.1
0.2% 1.9% 2.9% 1.4% 2.2% -0.1% -0.1% 6.4% 7.6% 7.5% 6.4% 5.7% 14.1% 14.3% 15.5% 16.1% 17.7% 18.1% 19.0% 20.0% 19.6% 19.0% 17.6% 18.4% 15.2% 17.6% 20.2% 21.3% 21.6% 22.6% 23.7% 24.8% 24.1% 23.0% 23.3% 25.0% 26.3% 26.8% 28.4% 28.6%
174.0 19.8 12.9 27.8 18.5 9.7 7.9 21.3 7.9 9.3 2.8 2.2 2.1 2.0 1.6 1.4 1.3 1.3 1.3 1.2 2.5 1.1 2.2 2.0 1.5 1.4 1.4 1.0 0.2 0.2 1.1 1.2 1.0 0.9 0.9 1.1 0.3 0.2
Per Share
0.15 0.46 0.85 0.99 1.18 0.78 0.52 0.83 0.94 1.82 1.96 2.22 2.28 2.31 2.68 3.32 3.16 2.85 2.61 2.17 2.23 2.25 2.61 2.34 6.95 7.30 7.15 7.52 2.94 2.39 2.18 1.96 1.23 1.24 1.52 1.67 2.68 2.80 2.86 2.37
13.56 14.19 14.76 15.26 15.26 15.43 15.18 15.12 15.22 15.48 15.70 15.91 16.50 16.80 17.56 17.42 16.99 16.91 16.09 15.18 14.12 14.43 14.35 14.90 15.40 14.34 14.24 14.33 14.42 14.73 14.95 15.26 15.35 15.14 15.24 15.39 15.68 15.99 16.09 16.35
0.07 0.57 0.87 0.41 0.66 -0.03 -0.03 1.85 2.25 2.19 2.02 1.81 5.88 7.52 8.10 8.36 9.16 9.89 10.18 10.52 10.26 10.01 6.86 9.79 5.00 5.18 7.16 7.88 7.80 8.26 8.50 8.81 6.87 6.60 8.83 9.86 10.60 8.00 11.56 8.64
1.40 2.11 2.54 2.37 2.41 2.41 2.27 2.56 2.68 3.33 3.25 3.13 3.32 2.92 3.05 3.84 2.92 3.54 3.23 2.61 4.07 4.17 5.17 5.20 4.16 2.67 1.47 1.26 1.54 2.45 3.11 3.05 2.89 1.96 1.87 2.27 2.90 3.05 3.06 3.44

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?